Advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression.
VIEW PRODUCT PIPELINEAbout
We are a neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing innovative therapeutics to improve the lives of people living with neurological and psychiatric disorders..
Read MoreLatest News
Xenon to Present at Stifel 2025 Virtual CNS Forum
Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update
Xenon to Present at the 45th Annual TD Cowen Healthcare Conference
Xenon to Report Q4 and Full Year 2024 Financial Results on February 27, 2025
View All News >
Investors
Visit our Investor page for News Releases, Annual & Quarterly Reports, Webcasts & Events
View Investor Area
